MedPath

A study to measure the zinc level in blood of children with severe pneumonia and to find out the effect of zinc supplementation ( given for 14 days ) in those children on recurrence or further attacks of pneumonia in the next 3 months.

Phase 3
Completed
Conditions
Health Condition 1: null- Pneumonia
Registration Number
CTRI/2012/11/003105
Lead Sponsor
Dr Aditi Baruah
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
560
Inclusion Criteria

children aged 2 â?? 60 months with severe pneumonia [who satisfy the World Health Organization (WHO) case definition of severe pneumonia ie Fever, Cough, Fast breathing (>= 50 / min in 2 mo â?? 12 mo and >= 40 / min in 1 â?? 5 yrs) and chest indrawing , requiring admission

Exclusion Criteria

1) Very severe pneumonia as per WHO case definition

2)Severe acute malnutrition

3)Child with Tuberculosis (of any system)

4)Known case of congenital heart disease

5)Present episode associated with allergic diseases or asthma

6)History of intake of Zinc in past three months

7)With an associated clinical diagnosis of diarrhea

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
i) Blood collection for zinc estimation <br/ ><br> ii)Time taken in hours for clinical resolution <br/ ><br>Timepoint: Blood collection within 24 hours
Secondary Outcome Measures
NameTimeMethod
i)Duration of hospital stay in completed days <br/ ><br>ii)Total number of episodes of fever and cough with fast breathing (50 or more per min in 2 mo â?? 12 mo and 40 or more per min in <br/ ><br>1 â?? 5 yrs) in next three months <br/ ><br> <br/ ><br>Timepoint: i) Duration of hospital stay from admission to discharge <br/ ><br>ii) No of episodes of pneumonia from discharge to 3 months
© Copyright 2025. All Rights Reserved by MedPath